Minimum Residual Disease in Acute Lymphoblastic Leukemia

5 意见
administrator
administrator
08/04/23

In this segment, Jeffrey Lancet, MD; Raoul Tibes, MD; and Mark R. Litzow, MD, describe various methodologies in monitoring minimum residual disease in acute lymphoblastic leukemia.

  • 类别

显示更多

0 注释 排序方式

没有找到评论

脸书评论

下一个